Estimation of outer membrane permeability of carbapenem antibiotics to Pseudomonas aeruginosa

Journal of Infection and Chemotherapy

Volumn 5, Issue 3, 1999, Pages 168-170

  Iyobe, Shizuko ^a   Watanabe, Masato ^b   Mitsuhashi, Susumu ^b   Inoue, Matsuhisa ^a,c  

^a GUNMA UNIVERSITY   (Japan)

^b Episome Institute   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Carbapenem; Outer membrane permeability; Pseudomonas aeruginosa

Indexed keywords

BIAPENEM; CARBAPENEM DERIVATIVE; CEFTAZIDIME; IMIPENEM; MEROPENEM; PANIPENEM;

ARTICLE; BACTERIAL OUTER MEMBRANE; CONTROLLED STUDY; DRUG PENETRATION; DRUG RESEARCH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 0032872406     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560050028     Document Type: Article

References (15)

1. Bryan LE. Resistance to antimicrobial agents: the general nature of the problem and the basis of resistance. In: Dogget RG, editor. Pseudomonas aeruginosa: clinical manifestations of infection and current therapy. New York: Academic; 1979:219-70.
2. Mitsuhashi S, Inoue M. Mechanisms of resistance to β-lactam antibiotics. In: Mitsuhashi S, editor. Beta-lactam antibiotics. Tokyo: Japan Scientific Societies; 1981:41-56.
3. Hancock REW, Woodruff WA. Roles of porin and β-lactamase in β-lactam resistance of Pseudomonas aeruginosa. Rev Infect Dis 1988;10:770-5.
4. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother 1989;33:1831-6.
5. Zimmermann W, Rosselet A. Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics. Antimicrob Agents Chemother 1977;12:368-72.
6. Sawai T, Matsuba K, Yamagishi S. A method for measuring the outer membrane permeability of β-lactam antibiotics in gram-negative bacteria. J Antibiotics 1977;30:1134-6.
7. Sawai T, Hiruma R, Kawana N, Kaneko M, Taniyasu F, Inami A. Outer membrane permeation of β-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrob Agents Chemother 1982;22:585-92.
8. Trias J, Dufresne J, Levesque RC, Nikaido H. Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1989;33:1201-6.
9. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991;35:147-51.
10. Bush K, Jacoby GA, Medeiros A. A functional classification for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1221-33.
11. Iyobe S, Tsunoda M, Mitsuhashi S. Cloning and expression in Enterobacteriaceae of the extended-spectrum β-lactamase gene from a Pseudomonas aeruginosa plasmid. FEMS Microbiol Lett 1994;175-80.
12. Nikaido H, Rosenberg EY, Foulds J. Porin channels in Escherichia coli: studies with β-lactams in intact cells. J Bacteriol 1983;153:232-40.
13. Liu W, Nikaido H. Contribution of the cell-surface-associated enzyme in the Zimmermann-Rosselet assay of outer membrane permeability to β-lactam antibiotics. Antimicrob Agents Chemother 1991;35:177-9.
14. Nikaido H, Liu W, Rosenberg EY. Outer membrane permeability and β-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents. Antimicrob Agents Chemother 1990;34:337-42.
15. Kohler T, Michea-Hamzehpour M, Epp SF, Pechere JC. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob Agents Chemother 1999;43:424-7.